Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 3
1952 5
1953 3
1954 3
1955 6
1956 4
1957 4
1960 5
1961 1
1962 2
1963 5
1964 1
1965 1
1967 1
1968 1
1971 1
1972 1
1973 2
1974 3
1975 1
1976 5
1977 2
1978 5
1979 6
1980 8
1981 3
1982 7
1983 7
1984 5
1985 10
1986 19
1987 13
1988 17
1989 9
1990 10
1991 13
1992 13
1993 16
1994 18
1995 14
1996 19
1997 15
1998 20
1999 20
2000 17
2001 20
2002 20
2003 21
2004 30
2005 28
2006 32
2007 30
2008 34
2009 41
2010 31
2011 43
2012 49
2013 35
2014 37
2015 39
2016 36
2017 38
2018 41
2019 41
2020 49
2021 45
2022 40
Text availability
Article attribute
Article type
Publication date

Search Results

1,039 results
Results by year
Filters applied: . Clear all
Page 1
Archaea Biotechnology.
Pfeifer K, Ergal İ, Koller M, Basen M, Schuster B, Rittmann SKR. Pfeifer K, et al. Among authors: koller m. Biotechnol Adv. 2021 Mar-Apr;47:107668. doi: 10.1016/j.biotechadv.2020.107668. Epub 2020 Dec 1. Biotechnol Adv. 2021. PMID: 33271237 Free article. Review.
Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice.
Pak HH, Haws SA, Green CL, Koller M, Lavarias MT, Richardson NE, Yang SE, Dumas SN, Sonsalla M, Bray L, Johnson M, Barnes S, Darley-Usmar V, Zhang J, Yen CE, Denu JM, Lamming DW. Pak HH, et al. Among authors: koller m. Nat Metab. 2021 Oct;3(10):1327-1341. doi: 10.1038/s42255-021-00466-9. Epub 2021 Oct 18. Nat Metab. 2021. PMID: 34663973 Free PMC article.
Editorial.
Köller M. Köller M. Wien Med Wochenschr. 2022 Apr;172(5-6):101. doi: 10.1007/s10354-022-00928-z. Epub 2022 Mar 24. Wien Med Wochenschr. 2022. PMID: 35325336 No abstract available.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Coens C, Pe M, Dueck AC, Sloan J, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Devlin N, Dorme L, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Bottomley A; Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium. Coens C, et al. Among authors: koller m. Lancet Oncol. 2020 Feb;21(2):e83-e96. doi: 10.1016/S1470-2045(19)30790-9. Lancet Oncol. 2020. PMID: 32007209 Free article. Review.
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
Peterhoff D, Glück V, Vogel M, Schuster P, Schütz A, Neubert P, Albert V, Frisch S, Kiessling M, Pervan P, Werner M, Ritter N, Babl L, Deichner M, Hanses F, Lubnow M, Müller T, Lunz D, Hitzenbichler F, Audebert F, Hähnel V, Offner R, Müller M, Schmid S, Burkhardt R, Glück T, Koller M, Niller HH, Graf B, Salzberger B, Wenzel JJ, Jantsch J, Gessner A, Schmidt B, Wagner R. Peterhoff D, et al. Among authors: koller m. Infection. 2021 Feb;49(1):75-82. doi: 10.1007/s15010-020-01503-7. Epub 2020 Aug 21. Infection. 2021. PMID: 32827125 Free PMC article.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: koller m. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study.
van Delden C, Stampf S, Hirsch HH, Manuel O, Meylan P, Cusini A, Hirzel C, Khanna N, Weisser M, Garzoni C, Boggian K, Berger C, Nadal D, Koller M, Saccilotto R, Mueller NJ; Swiss Transplant Cohort Study. van Delden C, et al. Among authors: koller m. Clin Infect Dis. 2020 Oct 23;71(7):e159-e169. doi: 10.1093/cid/ciz1113. Clin Infect Dis. 2020. PMID: 31915816 Free PMC article.
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG. Jankovic J, et al. Among authors: koller m. JAMA Neurol. 2018 Oct 1;75(10):1206-1214. doi: 10.1001/jamaneurol.2018.1487. JAMA Neurol. 2018. PMID: 29913017 Free PMC article. Clinical Trial.
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.
Glück V, Grobecker S, Köstler J, Tydykov L, Bertok M, Weidlich T, Gottwald C, Salzberger B, Wagner R, Zeman F, Koller M, Gessner A, Schmidt B, Glück T, Peterhoff D. Glück V, et al. Among authors: koller m. Infection. 2022 Apr;50(2):439-446. doi: 10.1007/s15010-021-01703-9. Epub 2021 Sep 25. Infection. 2022. PMID: 34562263 Free PMC article.
[Basic principles of fracture healing].
Rausch V, Seybold D, Königshausen M, Köller M, Schildhauer TA, Geßmann J. Rausch V, et al. Among authors: koller m. Orthopade. 2017 Aug;46(8):640-647. doi: 10.1007/s00132-017-3449-8. Orthopade. 2017. PMID: 28718007 Review. German.
1,039 results